XOLREMDI
NDC 83296-100, mavorixafor, capsule, gelatin coated, from X4 Pharmaceuticals, Inc..
- Product NDC
- 83296-100
- Status
- Listed
- Labeler
- X4 Pharmaceuticals, Inc.
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA218709
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83296-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MAVORIXAFOR100 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83296-100-12 | 83296010012 | 120 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-12) |
| 83296-100-60 | 83296010060 | 60 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-60) |
| 83296-100-90 | 83296010090 | 90 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7f3a5ee3-ca73-4876-85a0-ed1e108a2237
Use it
Look up 83296-100 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83296-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83296-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.